Showing results (2061-2070 of 2,657) with videos related to
Sort By:
Pageof 266
Annals of Neurology|November 6, 2021
miR-146b Protects the Perinatal Brain against Microglia-Induced HypomyelinationCindy Bokobza, Pooja Joshi, Anne-Laure Schang, et al.Epilepsy & Behavior : E&B|July 6, 2024
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studiesEdward Faught, Hervé Besson, Wendyl D'Souza, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter StudyAlexandre Cochet, Victor Besson, Aurélie Bertaut, et al.Journal of Neurology|March 4, 2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysisJerzy P Szaflarski, Hervé Besson, Wendyl D'Souza, et al.Radiology|April 4, 2018
Rapid Contour-based Segmentation for 18F-FDG PET Imaging of Lung Tumors by Using ITK-SNAP: Comparison to Expert-based SegmentationFlorent L Besson, Théophraste Henry, Céline Meyer, et al.La Revue De Medecine Interne|November 26, 2016
[Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases]O Lidove, N Belmatoug, R Froissart, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA groupE Tchernonog, P Faurie, P Coppo, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 16, 2023
Pathways linking aging and atheroprotection in Mif-deficient atherosclerotic miceChristine Krammer, Bishan Yang, Sabrina Reichl, et al.Blood|August 26, 2011
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinibJorge E Cortes, Hagop M Kantarjian, Tim H Brümmendorf, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2021
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and NumberLaurie Besson, Benoite Mery, Magali Morelle, et al.Pageof 266